Completed PHASE4 INTERVENTIONAL 2-arm NCT00931788

Preventing Recurrent Vascular Events in Patients With Stroke or Transient Ischemic Attack (PREVENTION)

Preventing Recurrent Vascular Events and Neurological Worsening Through Intensive Organized Case-Management (PREVENTION) Trial

Sponsor: Alberta Heritage Foundation for Medical Research

Conditions Ischemic Stroke Transient Ischemic Attacks

Interventions Antihypertensive agents and lipid lowering therapy Usual Care

Updated 6 times since 2017 Last updated: Oct 10, 2018 Started: Jan 31, 2009 Primary completion: May 31, 2013 Completion: Nov 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Ischemic Stroke and Transient Ischemic Attacks and is currently completed. Alberta Heritage Foundation for Medical Research leads this study, which shows 6 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Nov 2018 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — Nov 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alberta Heritage Foundation for Medical Research
Heart and Stroke Foundation of Canada
University of Alberta

Data source: University of Alberta

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Edmonton, Canada